{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:13:24Z","timestamp":1788801204810,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00259-023-06122-6","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T04:23:16Z","timestamp":1675138996000},"page":"1689-1698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of whole-body DW-MRI with 2-[18F]FDG PET for staging and treatment monitoring of children with Langerhans cell histiocytosis"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1646-4876","authenticated-orcid":false,"given":"Lucia","family":"Baratto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramyashree","family":"Nyalakonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok J.","family":"Theruvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Sarrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina Elizabeth","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"States","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Aboian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike E.","family":"Daldrup-Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"6122_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/pbc.21504","volume":"51","author":"H Stalemark","year":"2008","unstructured":"Stalemark H, Laurencikas E, Karis J, Gavhed D, Fadeel B, Henter JI. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 2008;51:76\u201381.","journal-title":"Pediatr Blood Cancer"},{"key":"6122_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/pbc.20884","volume":"48","author":"RD Alston","year":"2007","unstructured":"Alston RD, Tatevossian RG, McNally RJ, Kelsey A, Birch JM, Eden TO. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatr Blood Cancer. 2007;48:555\u201360.","journal-title":"Pediatr Blood Cancer"},{"key":"6122_CR3","unstructured":"The WHO Classification of Tumours Editorial Board. WHO Classification of tumours soft tissue and bone tumours, 5th ed. Lyon: IARC Press; 2020."},{"key":"6122_CR4","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1182\/blood.2019000934","volume":"135","author":"C Rodriguez-Galindo","year":"2020","unstructured":"Rodriguez-Galindo C, Allen CE. Langerhans cell histiocytosis. Blood. 2020;135:1319\u201331.","journal-title":"Blood"},{"key":"6122_CR5","doi-asserted-by":"crossref","unstructured":"Kilpatrick SE, Wenger DE, Gilchrist GS, Shives TC, Wollan PC, Unni KK. Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer. 1995;76:2471\u20132484.","DOI":"10.1002\/1097-0142(19951215)76:12<2471::AID-CNCR2820761211>3.0.CO;2-Z"},{"key":"6122_CR6","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1182\/blood-2012-09-455774","volume":"121","author":"H Gadner","year":"2013","unstructured":"Gadner H, Minkov M, Grois N, et al. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013;121:5006\u201314.","journal-title":"Blood"},{"key":"6122_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/mpo.1178","volume":"37","author":"C Titgemeyer","year":"2001","unstructured":"Titgemeyer C, Grois N, Minkov M, Flucher-Wolfram B, Gatterer-Menz I, Gadner H. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med Pediatr Oncol. 2001;37:108\u201314.","journal-title":"Med Pediatr Oncol"},{"key":"6122_CR8","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1067\/mpd.2001.111331","volume":"138","author":"H Gadner","year":"2001","unstructured":"Gadner H, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans\u2019 cell histiocytosis. J Pediatr. 2001;138:728\u201334.","journal-title":"J Pediatr"},{"key":"6122_CR9","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1182\/blood-2007-08-106211","volume":"111","author":"H Gadner","year":"2008","unstructured":"Gadner H, Grois N, Potschger U, et al. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood. 2008;111:2556\u201362.","journal-title":"Blood"},{"key":"6122_CR10","unstructured":"Milen Minkov NG, Kenneth McClain, et al. Langherans cell histiocytosis; Histiocyte Society; evaluation and treatment guidelines. http:\/\/www.hematologie-amc.nl\/bestanden\/hematologie\/bijlagennietinDBS\/SocietyLCHTreatmentGuidelines.PDF. 2009."},{"key":"6122_CR11","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.2967\/jnumed.120.259747","volume":"62","author":"L Baratto","year":"2021","unstructured":"Baratto L, Hawk KE, States L, et al. PET\/MRI improves management of children with cancer. J Nucl Med. 2021;62:1334\u201340.","journal-title":"J Nucl Med"},{"key":"6122_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1055\/s-2008-1027345","volume":"180","author":"M Steinborn","year":"2008","unstructured":"Steinborn M, Wortler K, Nathrath M, Schoniger M, Hahn H. Rummeny EJ [Whole-body MRI in children with Langerhans cell histiocytosis for the evaluation of the skeletal system]. Rofo. 2008;180:646\u201353.","journal-title":"Rofo"},{"key":"6122_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41598-018-36501-1","volume":"9","author":"JR Kim","year":"2019","unstructured":"Kim JR, Yoon HM, Jung AY, Cho YA, Seo JJ, Lee JS. Comparison of whole-body MRI, bone scan, and radiographic skeletal survey for lesion detection and risk stratification of Langerhans cell histiocytosis. Sci Rep. 2019;9:317.","journal-title":"Sci Rep"},{"key":"6122_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s12149-012-0635-y","volume":"26","author":"HJ Lee","year":"2012","unstructured":"Lee HJ, Ahn BC, Lee SW, Lee J. The usefulness of F-18 fluorodeoxyglucose positron emission tomography\/computed tomography in patients with Langerhans cell histiocytosis. Ann Nucl Med. 2012;26:730\u20137.","journal-title":"Ann Nucl Med"},{"key":"6122_CR15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s11604-017-0668-1","volume":"35","author":"D Albano","year":"2017","unstructured":"Albano D, Bosio G, Giubbini R, Bertagna F. Role of (18)F-FDG PET\/CT in patients affected by Langerhans cell histiocytosis. Jpn J Radiol. 2017;35:574\u201383.","journal-title":"Jpn J Radiol"},{"key":"6122_CR16","doi-asserted-by":"crossref","unstructured":"Rashidi A, Baratto L, Theruvath AJ, et al. Diagnostic accuracy of 2-[(18)F]FDG-PET and whole-body DW-MRI for the detection of bone marrow metastases in children and young adults. Eur Radiol. 2022.","DOI":"10.1007\/s00256-022-04240-0"},{"key":"6122_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1470-2045(14)70021-X","volume":"15","author":"C Klenk","year":"2014","unstructured":"Klenk C, Gawande R, Uslu L, et al. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET\/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study. Lancet Oncol. 2014;15:275\u201385.","journal-title":"Lancet Oncol"},{"key":"6122_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1148\/radiol.2020192508","volume":"296","author":"AJ Theruvath","year":"2020","unstructured":"Theruvath AJ, Siedek F, Muehe AM, et al. Therapy response assessment of pediatric tumors with whole-body diffusion-weighted MRI and FDG PET\/MRI. Radiology. 2020;296:143\u201351.","journal-title":"Radiology"},{"key":"6122_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/MPH.0000000000001465","volume":"41","author":"L Uslu-Besli","year":"2019","unstructured":"Uslu-Besli L, AtayKapucu LO, Karadeniz C, et al. Comparison of FDG PET\/MRI and FDG PET\/CT in pediatric oncology in terms of anatomic correlation of FDG-positive lesions. J Pediatr Hematol Oncol. 2019;41:542\u201350.","journal-title":"J Pediatr Hematol Oncol"},{"key":"6122_CR20","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.2147\/IJGM.S327134","volume":"14","author":"J Niu","year":"2021","unstructured":"Niu J, Liang J, Feng Q, et al. (18)F-FDG PET\/MR assessment of pediatric Langerhans cell histiocytosis. Int J Gen Med. 2021;14:6251\u20139.","journal-title":"Int J Gen Med"},{"key":"6122_CR21","doi-asserted-by":"publisher","first-page":"59492","DOI":"10.18632\/oncotarget.17752","volume":"8","author":"A Surov","year":"2017","unstructured":"Surov A, Meyer HJ, Wienke A. Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis. Oncotarget. 2017;8:59492\u20139.","journal-title":"Oncotarget"},{"key":"6122_CR22","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201368.","journal-title":"J Clin Oncol"},{"key":"6122_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/nbm.1689","volume":"24","author":"X Wu","year":"2011","unstructured":"Wu X, Kellokumpu-Lehtinen PL, Pertovaara H, et al. Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B cell lymphoma\u2013a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography\/computed tomography. NMR Biomed. 2011;24:1181\u201390.","journal-title":"NMR Biomed"},{"key":"6122_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/pbc.21782","volume":"52","author":"M Phillips","year":"2009","unstructured":"Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2009;52:97\u2013101.","journal-title":"Pediatr Blood Cancer"},{"key":"6122_CR25","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1007\/s00330-020-06732-w","volume":"30","author":"S Kharuzhyk","year":"2020","unstructured":"Kharuzhyk S, Zhavrid E, Dziuban A, Sukolinskaja E, Kalenik O. Comparison of whole-body MRI with diffusion-weighted imaging and PET\/CT in lymphoma staging. Eur Radiol. 2020;30:3915\u201323.","journal-title":"Eur Radiol"},{"key":"6122_CR26","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.2174\/1573405616666200218124926","volume":"16","author":"L Soydan","year":"2020","unstructured":"Soydan L, Demir AA, Torun M, Cikrikcioglu MA. Use of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in gastric cancer staging. Curr Med Imaging. 2020;16:1278\u201389.","journal-title":"Curr Med Imaging"},{"key":"6122_CR27","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00247-018-4071-6","volume":"48","author":"R Regacini","year":"2018","unstructured":"Regacini R, Puchnick A, Luisi FAV, Lederman HM. Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents? Pediatr Radiol. 2018;48:638\u201347.","journal-title":"Pediatr Radiol"},{"key":"6122_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jmri.20683","volume":"24","author":"D Le Bihan","year":"2006","unstructured":"Le Bihan D, Poupon C, Amadon A, Lethimonnier F. Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging. 2006;24:478\u201388.","journal-title":"J Magn Reson Imaging"},{"key":"6122_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1148\/radiol.14131732","volume":"273","author":"JF Schafer","year":"2014","unstructured":"Schafer JF, Gatidis S, Schmidt H, et al. Simultaneous whole-body PET\/MR imaging in comparison to PET\/CT in pediatric oncology: initial results. Radiology. 2014;273:220\u201331.","journal-title":"Radiology"},{"key":"6122_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/pbc.24367","volume":"60","author":"R Haupt","year":"2013","unstructured":"Haupt R, Minkov M, Astigarraga I, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60:175\u201384.","journal-title":"Pediatr Blood Cancer"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06122-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06122-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06122-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T14:34:35Z","timestamp":1682001275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06122-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6122"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06122-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]},"assertion":[{"value":"11 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}